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ABSTRACT
INFLUENCE OF PHYSICAL STATES OF BIOACTIVE COMPONENTS
(CRYSTALIZED VERSUS SOLUBILIZED) AND OIL COMPOSITION ON
BIOACCESSIBILITY AND BIOAVAILABILITY
MAY 2014
ZIYUAN XIA, B.A., FLORIDA INSTITUTE OF TECHNOLOGY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor H. Xiao

β-carotene, a precursor to Vitamin A, is considered as a potent nutraceutical in foods
and beverages due to its ability of reducing the incidences of certain chronic diseases.
However, because of its lipophilicity, its use is certainly limited. In this study, we
investigated the bioaccessibilities of solubilized β-carotene and β-carotene crystals
through a simulated gastrointestinal digestion model. Three systems were compared in
the first case study: (1). pre-dissolved β-carotene nanoemulsion (d< 200nm); (2). corn
oil emulsion

(d< 200nm) with β-carotene crystals being added before digestion; (3).

phosphate buffer saline with β-carotene being added before digestion. Oil-in-water
nanoemulsions were formed by high-pressure homogenization using Tween 20 as
emulsifier and corn oil as carrier oil and then they were subjected to a simulated
mouth, stomach and small intestine digestion. The rate and extent of free fatty acid
production in small intestine decreased in the order (2)>(1)>(3); whereas the
β-carotene bioaccessibility decreased in the order (1)>>(2)>(3). In system (3), even
without any fat content, there is still noticeable consumption of NaOH, which is due to
	
  

v	
  

the ester bonds existing in the non-ionic surfactant (Tween 20). In the second case
study, we developed two comparing groups by differentiating their oil concentration
(20%, 4% respectively). The bioaccessibility of the high fat group is only half of the
low fat group due to the insufficient digestion of fat in the former group. In the third
case study, the bioaccessibility of nobiletin with different physical states (crystalized
vs solubilized) and in different delivery system (conventional emulsion vs
nanoemulsion) was compared. Not like β-carotene, the bioaccessibility of nobiletin as
crystals in slightly lower than it is as solubilized state. Meanwhile, in conventional
emulsion, the bioaccessibility is slightly lower than in nanoemulsion. This study
provides important information for developing effective delivery systems for
lipophilic bioactive components in food and beverage applications.

Keywords: nanoemulsions; delivery systems; β-carotene crystals; solubilized
β-carotene ; bioaccessibility; digestion.
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CHAPTER 1
LITERATURE REVIEW
1.1 General Introduction of Bioactive Components
There is currently great interest in developing functional foods within the food
industries. A functional food refers food that in addition to providing a short-term
nutritional function has positive effects on the long-term maintenance of health. There
is also a perceived commercial advantage in replacing existing synthetic additives
with new high performance natural additives (Wiseman 1999). However, most of the
bioactive components of these functional foods are hydrophobic which are hard to
dissolve in water and then less bioaccessible to human gastrointestinal tract.
Researchers are trying to find some ways to modify their physical states, in order to
fortify their overall benefits to human health. Many nutraceutical and functional food
components would beneﬁt from being encapsulated in appropriate edible delivery
systems, including vitamins, bioactive peptides, antimicrobials, antioxidants, ﬂavors,
colors, minerals, and preservatives(Ubbink 2002, Shefer 2003, Chen 2006, Ubbink
2006). Some bioactive lipids are in crystalline state at room temperature in their pure
form, e.g., carotenoids. The crystalline nature of these lipids may provide challenges
in the manufacture of certain types of food products, or they may adversely affect the
long-term stability or organoleptic properties of the final product (McClements,
Decker et al. 2009).
1.2 Study of β-carotene
It has been reported that β-carotene is the most important pro-vitamin A
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carotenoid found in foods and beverages (Rao and Rao 2007, Boon, McClements et al.
2010). The results of epidemiological studies suggest that β-carotene has biological
activities that may reduce the risk of certain chronic diseases, such as cancers,
cardiovascular disease, age-related macular degeneration, and cataracts (Omenn,
Goodman et al. 1996, Karppi, Laukkanen et al. 2012, Miller and Snyder 2012). The
bioavailability of β-carotene could be affected by dietary and physiological factors
such as dietary triglycerides, protein-energy malnutrition, food matrix, D-carotene
dietary history and B-carotene intake (Mittal 1983, Brubacher and Weiser 1985, Alam,
Brown et al. 1990, Poor, Bierer et al. 1993). A number of physicochemical and
physiological mechanisms have been proposed to account for low bioavailability and
high variability of β-carotene: β-carotene is trapped within the organic matrix of many
natural foods, which inhibits its release within the gastrointestinal tract (GIT);
β-carotene is highly insoluble in water and only slightly soluble in oil at ambient
temperatures, which limits its incorporation into many foods and may cause its
precipitation within the GIT; β-carotene must be released from the food matrix and
incorporated into mixed micelles before it can be absorbed; β-carotene is highly
susceptible to oxidation due to its conjugated double bond structure, which means that
it may degrade during storage (Castenmiller and West 1998, Elliott 1999, Huo,
Ferruzzi et al. 2007, Boon, McClements et al. 2010). It has been shown that the
bioavailability of β-carotene and other carotenoids can be improved by cooperating
them with digestible lipids (van Het Hof, West et al. 2000, Borel 2003, Thakkar,
Maziya-Dixon et al. 2007). When the lipid is digested by gastric and pancreatic
	
  

2	
  

lipases it forms free fatty acids that are incorporated along with bile acids and
phospholipids into mixed micelles that can solubilize and transport carotenoids to
epithelium cells (Tyssandier, Lyan et al. 2001).
Crystalline materials are often difficult to incorporate into liquid products because
of their tendency to aggregate and sediment, which causes problems with consistent
dosing since some of the bioactive component may not be ingested. The presence of
crystalline materials may also adversely affect the appearance, texture, and mouth feel
of commercial products so that consumers are unwilling to consume them, leading to
poor compliance with daily recommended intakes. However, β-carotene exists as
crystalline in ambient temperature. In order to investigate its bioavailability in its
natural state and mimic the way people take nutracuetical tablets, we co-administered
β-carotene crystals with oil-in-water emulsion delivery system to increase its
bioavailability in GIT.
1.3 Study of Nobiletin
Accumulating evidence has suggested that flavonoids found in fruits and
vegetables may have various health-promoting effects. Among those flavonoids,
polymethoxyflavones (PMFs) are a unique class of flavonoids and almost exclusively
exist in the citrus genus, particularly in the peels of sweet oranges (Citrus sinensis L.
Osbeck) and mandarin oranges(C. reticulate Blanco) (Li, Lo et al. 2006). PMFs have
been reported to have a series of biological activity, such as anti-inflammatory,
anti-carcinogenic, antioxidant, antiviral, and anti-atherogenic properties (Li, Pan et al.
2009). It is reported that citrus flavonoids including nobiletin exert an anti-invasive
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activity in mouse(Sato, Koike et al. 2002). However, as same as many a bioactive
agent, nobiletin is a non-polar compound with high melting point, low water-solubility,
and poor oral bioavailability (Brouwers, Brewster et al. 2009, Bevernage, Brouwers et
al. 2010, Kleberg, Jacobsen et al. 2010). Because of their tendency to precipitate and
sediment, it is difficult to incorporate many of these bioactive compounds into
commercial products, such as functional foods and beverages. The poor absorption of
crystalline compounds in the gastrointestinal tract (GIT) compared to soluble ones
reduces the amount of bioactive compound that reaches the blood circulation and
target tissues (Brouwers, Brewster et al. 2009, Kawabata, Wada et al. 2011, Wang and
Hou 2011). Many of these problems can be overcome by ensuring that the bioactive
component remains in a soluble state within the product during storage, as well as
during its passage throughout the GIT after ingestion.
The food industry may be able to overcome some of these potential problems by
using strategies developed within the pharmaceutical industry to increase the aqueous
solubility of crystalline hydrophobic drugs so as to improve their biopharmaceutical
properties (Brewster and Loftsson 2007, Brouwers, Brewster et al. 2009, Warren,
Benameur et al. 2010). A number of technological approaches have been investigated
by pharmaceutical researchers to achieve this goal such as converting the drug into
nanocrystals (Muller and Keck 2004), solubilizing the drug within colloidal delivery
systems (Hauss 2007, Ziani, Fang et al. 2012), and complexing the drug with various
polymers (Brewster and Loftsson 2007, Miller and Dahan 2012).
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1.4 In Vitro Digestion Model
In these three studies, we used a gastrointestinal model that simulates the mouth,
stomach and small intestine to test the stability of the delivery systems and
bioaccessibilities of bioactive components. The bioaccessibility is defined as the
fraction of an ingested component that is successfully transferred from the food matrix
into the mixed micelles that are formed by bile salts, phospholipids, and lipid
digestion products (i.e., free fatty acids and monoacylglycerols) (Huo, Ferruzzi et al.
2007, McClements and Xiao 2012). The pH-stat method is designed to simulate lipid
digestion within the small intestine (the place where the majority of lipid digestions
normally occur), and is based on measurements of the amount of free fatty acids (FFA)
released from lipids (usually triacylglcyerols) after lipase addition at pH values close
to 7.0. The sample to be analyzed is placed in a reaction chamber containing
appropriate concentrations of digestive components, such as lipase, bile salts, and
minerals. The concentration of alkali that must be titrated into the reaction cell to
neutralize any free fatty acids produced by lipid digestion, and thereby maintain the
pH at the initial value, is recorded versus time. In principle, the pH-stat method is
relatively simple and rapid to carry out and enables quantitative comparison of
different lipid formulations under similar conditions(Li, Hu et al. 2011).
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CHAPTER 2
INFLUENCE OF PHYSICAL STATES OF β-CAROTENE (CRYSTALIZED
VERSUS SOLIBILIZED) ON BIOACCESSIBILITY
2.1 Introduction
Beta-carotene, the most important pro-vitamin A carotenoid, are widely used in
beverages and food as natural colorants and nutraceuticals. Consuming β-carotene
may reduce the risk of certain chronic diseases, age-related macular degeneration and
cataracts(Gonnet, Lethuaut et al. 2010) However, the absorption of β-carotene from
many natural and processed foods is often highly variable and not efficient, which are
attributed to a number of causes: entrapment within food matrices; low
water-solubility; high melting point; poor chemical stability (Castenmiller and West
1998, Yonekura and Nagao 2007, Boon, McClements et al. 2010) Researchers
already showed that dissolved β–carotene in digestible oil and made into emulsion
could significantly increase its bioaccessibility (Hörter and Dressman 2001, Qian,
Decker et al. 2012, Rao, Decker et al. 2013) Meanwhile, a recent study showed
consumed carotenoids enriched vegetables with meal triacylglycerol could end up
with increased bioavailability (Goltz, Campbell et al. 2012). We proposed the
hypothesis that mix raw β–carotene crystals with lipid-based emulsion systems would
also facilitate the absorption of β–carotene human GIT.
The objective of this Chapter is to compare the bioaccessibilites between the
solubilized β-carotene and the crystalized β-carotene with emulsion systems through
in vitro digestion.
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2.2 Materials and Methods
2.2.1 Materials
Corn oil was purchased from a local supermarket. Beta-carotene (Type I, C9750)
was purchased from Sigma Chemical Company (St. Louis, MO) and Tween 20 was
purchased from Fisher Scientific Company (Fair Lawn, NJ). Lipase (from porcine
pancreas pancreatin) and bile extract (porcine) and Nile Red used for confocal
microscopy work were also purchased from Sigma. All other chemicals used were of
analytical grade. Double distilled water was used to prepare all solutions and
emulsions.
2.2.2 Preparation Of Beta-Carotene Enriched Nanomulsion
An oil phase was prepared by solubilizing 0.5% (w/w) of crystalline β-carotene
into corn oil, and then mild heated at 50 ºC for 5 min and stirred at room temperature
for about 1 hour to make sure crystals fully dissolve. An aqueous phase was formed
by mixing 0.5% (w/w) Tween 20 with aqueous buffer solution (10.0 mM phosphate
buffer saline (PBS), pH 7.0). Coarse emulsion was formed by mixing oil phase with
aqueous phase in 1:16 ratio, then use a high-speed blender (Tissue-Tearor, Biospec
Products, Bartlesville, OK) blending for 2 minutes at room temperature to make the
coarse emulsion, the coarse emulsion was then passed through a high pressure
microfluidizer (Model 101, Microfluidics, Newton, MA) three times at 9,000psi. The
corn oil emulsion was made by mixing corn oil with the aqueous phase described
above in 1:16 ratio followed by coarse blending and fine homogenizing through
microfluidizer. The freshly made nanoemulsion was stored at 20 ºC.
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2.2.3 Particle Characterization
The mean particle diameters (z-average) and particle size distribution of the
original emulsion and digesta after each digestion step were measured through a
dynamic light scattering instrument (Nano-ZS, Malvern Instruments, Worcestershire,
UK). Samples of each step were diluted 20 times by using the buffer of the same pH
as the samples. Then samples were placed to a capillary test tube and were loaded into
the instrument. After loading the sample, it was equilibrated about 60s before data was
collected over 10 sequential readings.
The electrical charge (ζ-potential) of the original emulsion and the digesta after
each digestion step were monitored using a micro-electrophoresis instrument
(Nano-ZS, Malvern Instruments, Worcestershire, UK). The same diluted samples used
above were used for measuring electrical charge..
2.2.4 Microstructural Analysis
The microstructural changes of fat through digestion were observed by using
confocal scanning fluorescence microscopy. The physical changes of β-carotene
crystals were observed through a cross-polarized lens equipped in a Nikon optical
microscope (C1 Digital Eclipse, Tokyo, Japan). In the set of experiments, samples
from each step were dyed with Nile Red (0.1%), while the oil phases of emulsion and
digesta were stained. All images were taken by using a 10x eyepiece and a 60x
objective lens (oil immersion).
2.2.5 In vitro Digestion
Three comparative groups were prepared, which were β-carotene-enriched
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nanoemulsion, β-carotene crystals in corn oil nanoemulsion and β-carotene crystals in
phosphate buffer saline (PBS). The concentrations of β-carotene in the three groups
were the same. Beta-carotene crystals were put into corn oil emulsion and PBS
respectively just before digestion started. Each sample was passed through a three-step
simulated GI model that consisted of a mouth, gastric, and small intestine phase. This
model was established and described in previous study (Mun and McClements 2006).
Mouth phase: Simulated saliva fluid (SSF), containing 3% mucin and various salts,
was prepared as described in previous studies(Sarkar, Goh et al. 2009, Mao and
McClements 2012). Ten ml of sample was placed in a beaker and mixed with 10 ml of
SSF to make the oil concentration to be 2%. The mixture was then adjusted to pH 6.8
and placed in a shaker at 100 rpm and 37 ºC for 10 min to mimic oral conditions
(Innova Incubator Shaker, 132 Model 4080, New Brunswick Scientific, New Jersey,
USA).
Gastric phase: Simulated gastric fluid (SGF) was prepared according to a
protocol described before (Sarkar, Goh et al. 2009). The “bolus” sample from the
mouth phase was mixed with SGF at a 1:1 mass ratio to make the final oil
concentration to be 1%. The mixture was then adjusted to pH 2.5 and placed in a
shaker at 100 rpm and 37 ºC for 10 min to mimic gastric conditions.
Small Intestine phase: Gastric digesta (30 ml) was incubated in a water bath (37 ºC)
for 10 min and then used NaOH solution to adjust the pH to 7.0. The 1.0 ml of CaCl2
solution, containing 110 mg of CaCl2 (pH 7.0, PBS) was added. Then 4 ml bile extract,
containing 187.5 mg bile extract (pH 7.0, PBS), was first added into the 30 ml digesta
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with stirring and the resulting system was adjusted to pH 7.0. Finally, 2.5 ml of
pancreatic suspension, containing 60 mg of lipase (pH 7.0, PBS) was added to the
solution. At this point, titration was started automatically. The pH-stat (Metrohm,
USA Inc.) was used to monitor and control the pH (at pH 7.0) of the digestion solution.
As the triacylglycerol of fat was digested into free fatty acids by lipolysis, the NaOH
solution (0.25 M) was added in to neutralize the pH (7.0). With the volume of NaOH,
the amount of free fatty acids released in the system can be calculated. The whole
digestion lasted for 2 hours. The calculation of free fatty acids released was described
in the previous study (Li and McClements 2010).
2.2.6 Bioaccessibility Determination
After in vitro digestion, digesta of each sample group was collected and centrifuged
(14000 rpm, Thermo Scientific, CL10 centrifuge) at 25 ºC for 40 min. Centrifuged
samples separated into three phases: sediment phase at the bottom, a relatively clear
water phase contained micelles in the middle, and sometimes an undigested oil phase
at top. The mixed micelles in the water phase were considered that entrapped the
bioactive components. The β-carotene was extracted using organic solvent
isopropanol-isooctane solution (1:1 volume ratio). Micelle phase or total digesta (0.2
ml) from the small intestine was added into 4.8 ml isopropanol-isooctane solution and
centrifuged at 4000 rpm at 25ºC for 10 min. Then the middle micelle phase was
passed through a syringe filter with the pore size of 0.45 um. Both the filtered and
unfiltered β-carotene concentration was analyzed using a UV-visible
spectrophotometer (Ultrospec 3000 pro, GE Health Sciences, USA) at the spectrum of
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450 nm. The concentration of β-carotene was converted from the absorbance by the
standard curve. The bioaccessibility was calculated using the following equation:

⎛ C
⎞
Bioaccessibility = 100 × ⎜ Micelle ⎟
⎜ C
⎟
⎝ Digesta ⎠
In this equation, CMicelle and CDigesta are the concentrations of β-carotene in the
filtered and unfiltered micelle fraction and in the overall sample (total digesta) after
the pH-stat experiment, respectively.
2.2.7 Statistical analysis
All measurements were performed at least twice on freshly prepared samples and
were reported as calculated means and standard deviations.
2.3 Results and Discussion
2.3.1 Nanoemulsion stability in digestion model

Mean Particle Diameter (nm)

1000

crystalized β-carotene
emulsion
solubilized β-carotene
emulsion

100
Original Mouth Stomach

SI

UF F Micelle
Micelle
Stages of Simulated GIT Model

Figure 1a. Influence of β-carotene on mean particle size. Influence of physical state
of β-carotene and in vitro digestion on the mean diameter of the particles in
oil-in-water nanoemulsions subjected to a simulated gastrointestinal model. Small
Intestine (SI), Unfiltered Micelle (UF Micelle), Filtered Micelle (F Micelle).
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Figure 1b. Particle size distribution of β-carotene solubilized group. Influence of
in vitro digestion on the particle size distribution of oil-in-water emulsions subjected
to a simulated gastrointestinal model. The physical state of β-carotene is crystal.
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Figure 1c. Particle size distribution of β-carotene crystals group. Influence of in
vitro digestion on the particle size distribution of oil-in-water emulsions subjected to a
simulated gastrointestinal model. The physical state of β-carotene is crystal
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Figure 2. The changes of morphologies of lipid. The changes of morphologies of
lipid in emulsion system during in vitro digestion. Images were taken by confocal
microscopy. The scale bars are 20um long. Pictures from left to right: original phase,
mouth phase, stomach phase, small intestine phase.

Figure 3. The change of microstructure of β-carotene crystals. The change of
microstructure of β-carotene crystals measured by crossed polarizer microscopy at
various in vitro digestion stages. The scale bars are 20um long. Pictures from left to
right are: after mouth digestion/after stomach digestion/after small intestine digestion.
All the initial nanoemulsions in solubilized β-carotene emulsion group (group 1)
and crystalized emulsion group (group 2) had relatively small mean particle diameters
(Figure 1a), monomodal particle size distributions (Figure 1b, 1c), which suggested
that under the initial solution condition (pH 7), they were stable enough to prevent
droplet aggregation. In the microscopy images, only small fine distributed particles
can be observed (Figure 2). After the mouth and stomach digestion, the particles still
remained in small size (d<270nm), which is also demonstrated in microscopy images.
The non-ionic surfactant (Tween 20) is a highly surface active molecule with a
relatively large hydrophilic head group. In mouth and stomach conditions, there is no
highly surface-active substance, and therefore the non-ionic surfactant molecules
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could still remain on the surface of the droplet. From the confocal microscopy images,
we can also tell most of the droplets still stayed in small sizes (Figure 2). The good
physical stability of the nanoemulsions under neutral (oral) and acidic (gastric)
environments observed in this study may therefore be attributed to the relatively
strong steric repulsion generated by the neutral hydrophilic head groups. As previous
studies have reported that the strong steric repulsion generated by the neutral
hydrophilic head groups is the contributor of the physical stability under neutral (oral)
and acidic (gastric) environments (Golding, Wooster et al. 2011, Nik, Langmaid et al.
2012, Qian, Decker et al. 2012).
After simulated small intestine digestion, the mean particle size of nanoemulsions
showed a large increase (Figure 1a), which was caused by droplet aggregation. It can
be proved by microscopy image (Figure 2) that until small intestine stage, small
droplets started to coalescent and aggregate. This suggested that when the
nanoemulsions exposed to small intestinal condition, their physical stability decreased
significantly. According to previous studies, several physicochemical mechanisms
may have been responsible for this change (Qian, Decker et al. 2012). The
replacement of the surface active species (i.e., phospholipids, bile salts, lipase, free
fatty acids, monoacyglycerols) with original non-ionic surfactant (Tween 20) may
lead to decrease of steric repulsion between droplets. On the other hand, after lipase
bound to the surface of the oil droplet, it digested triacylglycerols to free fatty acids
and monoacylglycerols and then changed the internal composition, structure and
properties of the lipid droplets. After the samples were centrifuged and the micelles
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phase was separated, the droplet sizes decreased dramatically (228nm, 279nm of two
groups respectively), which means the large aggregations were removed. After micelle
phase was filtered (pore size: 0.45um), the size went down further (107nm, 205nm of
two groups respectively). The images of the β-carotene crystals were captured by
crossed polarizer lens (Figure 3). The amount of crystals in the images decreased
obviously through in vitro digestion, we would assume that the β-carotene crystals
were solubilized. However, the decrease is because of the dilution of the system
instead of solubilization, which will be discussed in the bioaccessibility session.
We also measured the electrical charge of the sample of each step. The initial
nanoemulsions of both groups had little negative charges (Figure 2). Tween20 is
known as a non-ionic surfactant, however the anionic species in the lipid phase (i.e.,
phospholipids, free fatty acids) or the anionic impurities in surfactant, even the
hydroxide ions in water could contribute to the negative charge of the system (Qian,
Decker et al. 2012).
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Figure 4. Charge of the particles. Influence of physical state of β-carotene and in
vitro digestion on the charge (ζ-potential) of the particles in oil-in-water emulsions
subjected to a simulated gastrointestinal model.
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After simulated small intestine digestion, the digesta were collected and
centrifuged. The middle “micelle” phase was collected and its particle size and
electrical charges were measured (Figure 1a, 1b, 1c, 4). The data of both the filtered
(0.45um pore size) and unfiltered were showed. The sizes in the unfiltered groups
were larger than filtered groups indicated there was large particles or vesicles that
scattered light weakly in micelle phase. After filtration the size decreaed as expected,
suggesting that some large vesicles were filtered out (Figure1). The size in the
solubilized group is larger than the crystalized group mat be due to the β-carotene
molecule presenting more in the solubilized group and contributing to the formation of
micelles; in the crystalized group, most of the unsolubilized β-carotene crystals
sedimentated to the bottom after centrifugation and less amount participating in
forming micelles, therefore the micelles sizes are smaller. The electrical charges of the
unfiltered and filtered micelles are also negative (Figure 4) because of the anionic
species, such as bile salts, phospholipids, free fatty acids. In filtered micelle phase of
the solubilized β-carotene group, the number of electrical charge is less negative than
the crystalized β-carotene emulsion group, which is due to the average size of micelles
in the former group was larger than that of the latter group. The larger size lead to less
surface area compared with the smaller micelles, resulting in less negative charge
exposed.
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2.3.2 Lipid Digestion via In Vitro Digestion
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crystals in corn oil emulsion

1

crytals in PBS
0
0

20

40

60
80
Digestion time (min)

100

120

Free Fatty Acids Released (%)

Figure 5. Volume of NaOH. Influence of physical state of β-carotene on the pH-stat
titration curves of oil-in-water nanoemulsions. The curves show the volume of 0.25 M
NaOH solution that had to be added to the samples to maintain the pH at a constant
value of 7.
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Figure 6. Free fatty acids released percentage. Influence of physical state of
β-carotene on the pH-stat titration curves of oil-in-water nanoemulsions. The curves
show the calculated percentage of free fatty acids (FFA) released from the
nanoemulsions after digestion of the triacylglycerol phase by lipase.	
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   In this section, the rate and extent of lipid digestion in the small intestinal
digestion was monitored via pH-stat. This method measured the amount of free fatty
acids (FFAs) released from triglycerides under the digestion of lipase(McClements
and Li 2010). As expected, there was little change in the pH of the sample only
contained β-carotene crystals and PBS, because there is no fat in the system and no
FFAs released during digestion (Figure 5,6). The slight consumption of NaOH may
due to the impurities in non- ionic surfactant. A recent study showed that several
non-ionic surfactants have ester bonds that are susceptible to lipase digestion leading
to FFAs release (Li and McClements 2011). In the other two systems, there was a
dramatic increase in the first 20 minutes of digestion and then it started to level off
(Figure 5). The FFAs release profiles followed a similar trend as the NaOH
consumption (Figure 6). The trend suggested that lipase attached to the surface of the
lipid droplets rapidly and promoted triacylglycerol digestion.
2.3.3 In Vitro Digestion Bioaccessibility
In this section, we examined the β-carotene bioaccessibility under solubilized
status and crystalized status after it passed through the simulated gastrointestinal tract
model. Theoretically, the portion of β-carotene in “micelle” phase over the portion of
original β-carotene can represent the β-carotene bioaccessibility. The bioaccessibilty
was measure before and after filtration. It was assumed that the filtered sample could
be more practically represent the actual bioaccessibility of β-carotene because it could
remove any particles larger than 450nm that could not be absorbed by small intestine
epithelium cells. Practically, using filter may also lead to absorb β-carotene on its
surface, consequently decreased the concentration of β-carotene in “micelle” phase.
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Figure 7. Beta-carotene bioaccessibility. Effect of physical states of β-carotene on
bioaccessibility of β-carotene measured after centrifugation of emulsions passed
through an in vitro digestion model.
The lowest bioaccessibility (1.39%) was measured in filtered β-carotene crystals
with PBS (Figure 7). There are also comparatively low bioaccessibilities of
β-carotene crystals in corn oil emulsion (5.74%, 3.64%, unfiltered, filtered
respectively). The solubilized β-carotene emulsion enjoyed the highest
bioaccessibility. This is because when added β-carotene crystals in either corn oil
emulsion or PBS, most of the β-carotene still stayed unsolubilized. The β-carotene
crystals are too large for small micelles to solubilize and only solubilized β-carotene
molecules are small enough to be enraptured in micelles. Although β-carotene better
in corn oil emulsion than only in PBS, however compared with the solubilized
β-carotene emulsion, the solubilized part was still too few to have a high
bioaccessbility. These results suggested people to take solubilized β-carotene
supplements to get the best absorption in gastrointestinal tract.	
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2.4 Conclusions
This study showed the bioaccessibility of different physical states of β-carotene
are significantly different. In the three compare groups: (1) solubilized β-carotene
emulsion, (2) β-carotene crystals in corn oil emulsion, (3) β-carotene crystals in PBS,
the rate and extent of free fatty acid production in the small intestine decreased in the
order (2)>(1)>(3); whereas the β-carotene bioaccessibility decreased in the order
(1)>>(2)>(3). In system (3), even without any fat, there was still noticeable
consumption of NaOH, which was attributed to hydrolysis of the ester bonds in the
non-ionic surfactant (Tween 20). The low bioaccessibility (1.3%) of system (3) was
attributed to the fact that there were few free fatty acids produced to form mixed
micelles to solubilize β-carotene. The bioaccessibility of system (2) was also relatively
low (3.6%) compared to system (1) (42%), which suggests that crystalline β-carotene
is much less bioaccessible than soluble β-carotene .
The bioaccessibility of solubilized β-carotene entrapped in nanoemulsions was the
highest is because the free fatty acids produced through small intestine digestion
formed mixed micelles capable of solubilizing and transporting lipophilic compounds.
Crystalline β-carotene was not incorporated into mixed micelles easily, leading to a
reduced bioaccessibility. In the system with crystals in water, there was no free fatty
acids produced, so the bioaccessibility of β-carotene was low.
This study provides useful suggestions of how to take lipophilic nutraceutical
supplements: the best way is taking the bioactive components encapsulated
fat-contained emulsion products (i.e., functional food or functional drink) ; the second
choice is taking nutraceutical tablets with fat-contained emulsion (i.e., milk or salad
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dressing) or after eating meals (oil in meal forms natural emulsion through digestion).
The least effective way is taking the tablets with only water and an empty stomach.
The results are also important for designing effective delivery systems to encapsulate
and stabilize b-carotene for application within food, beverage, and pharmaceutical
products.
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CHAPTER 3
THE INFLUENCE OF OIL CONCENTRATION ON BETA-CAROTENE
BIOACCESSIBILITY
3.1 Introduction
It is suggested by epidemiological studies that there is a positive link between
higher dietary intake and tissue concentrations of carotenoids and lower risk of
chronic diseases including cardiovascular diseases, cancer and other chronic
diseases (Agarwal and Rao 2000, Johnson 2002, Elliott 2005). However, due to its
high hydrophobicity, β-carotene is reported to cause low solubility in aqueous
systems and lead to poor uptake in the body, which limits its use in food formulations.
The bioavailability of β-carotene in human body is also affected by many factors, i.e.
the state of the food matrix, food processing and the conditions in the gastrointestinal
(GI) tract (Castenmiller and West 1998). We assumed that the higher amount of oil
we put in emulsion system, the higher amount of β-carotene we can encapsulate in
emulsion system, consequently, higher bioaccessibility we can get.
The objective of this study is to compare the influence of high oil concentration
with low oil concentration on β-carotene nanoemulsion bioaccessibilty.
3.2 Materials and Methods
3.2.1 Materials
Corn oil was used as an example of a long chain triglyceride (LCT) and was
purchased from a local supermarket. Beta-carotene (Type I, C9750) was purchased
from Sigma Chemical Company (St. Louis, MO) and Tween 20 was purchased from
Fisher Scientific Company (Fair Lawn, NJ). Sucrose was purchased from Sigma	
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Chemical Company (St. Louis, MO). Their purities were > 98% based on HPLC
analysis. Lipase (from porcine pancreas pancreatin) and bile extract (porcine) and Nile
Red used for confocal microscopy work were also purchased from Sigma. All other
chemicals used were of analytical grade. Double distilled water was used to prepare
all solutions and emulsions.
3.2.2 Preparation of Beta-carotene Enriched Emulsion
For the high oil concentration group, the oil phase was prepared by dispersing 0.07%
(w/w) of crystalline β-carotene into corn oil 20% (w/w) followed by mild heating at
50 ºC for 5 min and stirring at ambient temperature for about 1 hour to make sure they
were fully dissolved. The aqueous phase was formed by mixing 5% (w/w) Tween 20
with aqueous buffer solution (10.0 mM phosphate buffer saline, pH 7.0) contained 60%
(w/w) sucrose, which was heated for 10 min with stirring to make sure completed
dissolution. Coarse emulsion was formed by mixing oil phase with aqueous phase in
1:16 ratio, then use a high-speed blender (Tissue-Tearor, Biospec Products,
Bartlesville, OK) blending for 2 minutes at ambient temperature to make the well
homogenized emulsion, the coarse emulsion was then passed through a high pressure
microfluidizer (Model 101, Microfluidics, Newton, MA) three times at 9,000psi.The
freshly made nanoemulsion was t stored at 20 ºC. The low fat group was made by
diluting the high fat group, which was made by above procedures, five folds to make
the fat concentration to be 4% (w/w) in the system.
3.2.3 Particle Characterization
The mean particle diameters (d43) and particle size distribution (PSD) of the
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nanoemulsions were measured after mouth, stomach and small intestine digestion
using a static light scattering instrument (Mastersizer 2000 Malvern Instruments). A
few drops of sample were dispersed in phosphate buffer saline (PBS) in the sample
chamber with agitation. The size of the particles in the filtered and unfiltered micelle
phase was measured using dynamic light scattering (ZetaSizer Nano, Malvern
Instruments). The original size of the nanoemulsion was measured through both static
and dynamic light scattering.
The electrical charge (ζ-potential) of the emulsion after each step digestion was
monitored using a micro-electrophoresis instrument (Nano-ZS, Malvern Instruments,
Worcestershire, UK). The same diluted samples used above were used for measuring
electrical charge.
3.2.4 In vitro Digestion
Two compare groups were created (20% oil, 4% oil). All the following steps were
applied as same to the two groups. Each sample was passed through a three-step
simulated GI model that consisted of a mouth, gastric, and small intestine phase. This
model was established and described in previuos study (Mun and McClements 2006).
Mouth phase: Simulated saliva fluid (SSF), containing 3% mucin and various salts,
was prepared as described in previous studies(Sarkar, Goh et al. 2009, Mao and
McClements 2012). Ten ml of sample was placed in a beaker and mixed with 10 ml of
SSF to make the oil concentration to be 2%. The mixture was then adjusted to pH 6.8
and placed in a shaker at 100 rpm and 37 ºC for 10 min to mimic oral conditions
(Innova Incubator Shaker, 132 Model 4080, New Brunswick Scientific, New Jersey,
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USA).
Gastric phase: Simulated gastric fluid (SGF) was prepared according to a
protocol described before (Sarkar, Goh et al. 2009). The “bolus” sample from the
mouth phase was mixed with SGF at a 1:1 mass ratio to make the final oil
concentration to be 1%. The mixture was then adjusted to pH 2.5 and placed in a
shaker at 100 rpm and 37 ºC for 10 min to mimic gastric conditions.
Small Intestine phase: Gastric digesta (30 ml) was incubated in a water bath (37 ºC)
for 10 min and then used NaOH solution to adjust the pH to 7.0. The 1.0 ml of CaCl2
solution, containing 110 mg of CaCl2 (pH 7.0, PBS) was added. Then 4 ml bile extract,
containing 187.5 mg bile extract (pH 7.0, PBS), was first added into the 30 ml digesta
with stirring and the resulting system was adjusted to pH 7.0. Finally, 2.5 ml of
pancreatic suspension, containing 60 mg of lipase (pH 7.0, PBS) was added to the
solution. At this point, titration was started automatically. The pH-stat (Metrohm,
USA Inc.) was used to monitor and control the pH (at pH 7.0) of the digestion solution.
As the triacylglycerol of fat was digested into free fatty acids by lipolysis, the NaOH
solution (0.25 M) was added in to neutralize the pH (7.0). With the volume of NaOH,
the amount of free fatty acids released in the system can be calculated. The whole
digestion lasted for 2 hours. The calculation of free fatty acids released was described
in the previous study (Li and McClements 2010).
3.2.5 Bioaccessibility Determination
After in vitro digestion, digesta of each sample group was collected and centrifuged
(14000 rpm, Thermo Scientific, CL10 centrifuge) at 25 ºC for 40 min. Centrifuged
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samples separated into three phases: sediment phase at the bottom, a relatively clear
water phase contained micelles in the middle, and sometimes an undigested oil phase
at top. The mixed micelles in the water phase were considered that entrapped the
bioactive components. The β-carotene was extracted using organic solvent
isopropanol-isooctane solution (1:1 volume ratio). Micelle phase or total digesta (0.2
ml) from the small intestine was added into 4.8 ml isopropanol-isooctane solution and
centrifuged at 4000 rpm at 25ºC for 10 min. Then the middle micelle phase was
passed through a syringe filter with the pore size of 0.45 um. Both the filtered and
unfiltered β-carotene concentration was analyzed using a UV-visible
spectrophotometer (Ultrospec 3000 pro, GE Health Sciences, USA) at the spectrum of
450 nm. The concentration of β-carotene was converted from the absorbance by the
standard curve. The bioaccessibility was calculated using the following equation:

⎛ C
⎞
Bioaccessibility = 100 × ⎜ Micelle ⎟
⎜ C
⎟
⎝ Digesta ⎠
In this equation, CMicelle and CDigesta are the concentrations of β-carotene in the
filtered and unfiltered micelle fraction and in the overall sample (total digesta) after
the pH-stat experiment, respectively.
3.2.6 Statistical analysis
All measurements were performed at least twice on freshly prepared samples and
were reported as calculated means and standard deviations.
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3.3 Results and discussion
3.3.1 Nanoemulsion stability in digestion model
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Figure 8a. Influence of oil concentration on mean particle size. Influence of oil
concentration and in vitro digestion on the mean diameter of the particles in
oil-in-water nanoemulsions subjected to a simulated gastrointestinal model.
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Figure 8b. Particle size distribution of 20% fat group. Influence of in vitro
digestion on the particle size distribution of oil-in-water emulsions subjected to a
simulated gastrointestinal model. The oil concentration is 20%.There are four stages:
initial, after (Aft) mouth, after (Aft) stomach, small intestine (SI).
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Figure 8c. Particle size distribution of 4% fat group. Influence of in vitro digestion
on the particle size distribution of oil-in-water emulsions subjected to a simulated
gastrointestinal model. The oil concentration is 4%.	
  
All the initial nanoemulsions had relatively small mean particle diameters
(d43=0.17, Figure 8a), monomodal particle size distributions (Figure 8b, 8c), which
suggested that they were stable to droplet aggregation under the initial solution
conditions (pH 7). After the mouth and stomach digestion, the main particle diameter
increased appreciably (d43>3). After incubated in simulated small intestine fluid, the
mean particle size of nanoemulsions showed a large increase, which can be explained
by droplet aggregation (Figure 8a). This suggested that when the nanoemulsions
exposed to small intestinal condition, their physical stability decreased a lot.
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Figure 9. Influence of oil concentration on particle charge. Influence of oil
concentration and in vitro digestion on the charge (ζ-potential) of the particles in
oil-in-water emulsions subjected to a simulated gastrointestinal model.
The initial nanoemulsions both had negative charges (-7.64mV/ -10.02mV,
Figure 9). Although Tween20 is a non-ionic surfactant, however, there may be
anionic impurities (e.g. free fatty acids and phospholipids) entrapping within the
surfactant or lipid phase that could adsorb to the oil-water interface and therefore
giving a negative charge to the droplets. After the small intestinal stage, the
particles charges appeared to be the most negative, which is due to adsorption of
anionic species (e.g., bile salts, phospholipids, lipases) to the droplets surfaces.
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Figure 10. Influence of oil concentration on micelles size. Influence of oil
concentration on the original particle size and micelle phase (represent by Z-average)
collected after digestion and centrifugation. Measurements were made before and after
filtration.
After simulated small intestine digestion, the digesta were collected and
centrifuged. Three layers formed afterwards: bottom sediment phase, middle micelle
phase and sometimes the undigested oil floated on the top. The “micelle” phase was
collected and filtered through a 0.45 um pore size filter. The particle size and
electrical charges of filtered and unfiltered micelles were measured (Figure 9, 10).
And the results were showed as unfiltered and filtered. The sizes in the unfiltered
groups are larger indicated that the middle phase are mainly mixed micelles and
thin-walled vesicles. After filtration the size decreased as expected, suggesting that
some large vesicles were filtered out. The electrical charges of the unfiltered and
filtered micelles are also negative (Figure 9) because of the anionic species, such as
bile salts, phospholipids, free fatty acids.
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Figure 11. Volume of NaOH. Influence of oil concentration on the pH-stat titration
curves of oil-in-water nanoemulsions. The curves show the volume of 0.25 M NaOH
solution that had to be added to the samples to maintain the pa constant value of 7.
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Figure 12. Free fatty acids released percentage. Influence of oil concentration on
the pH-stat titration curves of oil-in-water nanoemulsions. The curves show the
calculated percentage of free fatty acids (FFA) released from the nanoemulsions after
digestion of the triacylglycerol phase by lipase.	
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In this section, the rate and extent of lipid digestion in the small intestinal
digestion was measured via pH-stat. This method measured the amount of free fatty
acids (FFAs) released from triglycerides under the digestion of lipase(McClements
and Li 2010). As expected, the high oil content group (20%) consumed more NaOH
than the low oil content group (4%) (Figure 11). There was a dramatic increase in the
first 20 minutes of digestion and then it gradually leveled off (Figure 11). The FFAs
release profiles were a reverse of the NaOH consumption profiles. The high oil
content group was with a high NaOH consumption but a low FFAs percentage; the
low oil content was with a low NaOH consumption but a high FFAs percentage. This
is due to the bile salts concentration (46.88 mg/ml) used in the simulated digestion
system, which limited the concentration of fat (~4%) in the system. The FFAs release
profiles followed a similar trend as the NaOH consumption (Figure 12). The trend
suggested that lipase attached to the surface of the lipid droplets rapidly and promoted
triglycerol digestion.
3.3.3 In Vitro Digestion Bioaccessibility
In this section, we examined the β-carotene bioaccessibility under high fat
condition and low fat condition, after it passed through the simulated gastrointestinal
tract model. Theoretical, the portion of β-carotene in “micelle” phase over the portion
of original β-carotene can represent the β-carotene bioaccessibility. The
bioaccessibilty was measure before and after filtration. It was assumed that the filtered
sample could be more practically represent the actual bioaccessibility of β-carotene
because it could remove any particles larger than 450nm that could not be absorbed by	
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small intestine epithelium cells. It simulated the functions of mucus layer on the small
intestine epithelial cells.
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Figure 13. Influence of oil concentration on β-carotene bioaccessibility. Effect of oil
concentration on bioaccessibility of b-carotene measured after centrifugation of
emulsions passed through an in vitro digestion model.
The bioaccessibility of the filtered micelles of the 20% oil content sample is
84.4%, the same group of the 4% oil content sample is 39.4% (Figure 13). This is
because some of the β-carotene molecules were still entrapped in the undigested oil.
The bioaccessbility is proportional to the FFAs released. In the FFAs profile (Figure
12), the FFAs percentage of the 20% oil group is only half of 4% oil group;
correspondingly, the bioaccessibility of the high fat group is also only half of low fat
group (Figure 13). These results suggest us the high fat content oil with bioactive
compounds encapsulated, even can solubilize more bioactive components, after
digestion the bioavailable parts are smaller than the low fat content part.
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3.4 Conclusions
This study showed the bioaccessibility of β-carotene in the delivery systems
with different oil concentration. In the two compare groups: (1) 20% oil
concentration group (2) 4% oil concentration group, the rate and extent of free
fatty acid production in the small intestine decreased in the order (1)>(2); whereas
the β-carotene bioaccessibility decreased in the order (2)>(1). In the high fat group
even the total concentration of β-carotene is higher than the low fat concentration
due to the higher solubilization of β-carotene in the former group. However, the
bioaccessibility of the high fat group is only half of the low fat group due to the
insufficient digestion of fat in the former group.
The bioaccessibility of high fat concentration group (40%) is almost half of it
is in high fat group. This is because without enough bile salts and lipase, fat is not
able to be digested into free fatty acids and monoglycerids. Free fatty acids and
monoglycerids are the main components of micelles, not enough micelles means
not enough carriers can transfer β-carotene molecules. This end up with a lower
bioaccessibility of β-carotene in high fat group.
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CHAPTER 4
INFLUENCE OF PHYSICAL STATES AND SIZE OF EMULSION ON
NOBILETIN BIOACCESSIBILITY
4.1 Introduction
Nobiletin is an O-methylated flavone, which is a flavonoid isolated from citrus
peels like in tangerine. Like other polymethoxylated flavones found in citrus peel,
nobiletin was found to have anti-inflammatory and anti-tumor invasion, proliferation,
and metastasis in vitro and in vivo. Nobiletin was also found to have the potential
ability to inhibit cartilage degradation. (Henrotin, Lambert et al. 2011) Despite it’s
health-beneficial biofunctionalities, the lipophilic nature of nobiletin limits its water
solubility and oral bioavailability.
Emulsion-based delivery systems are being developed to encapsulate, protect, and
release these non-polar compounds. In vitro digestion models are needed to test the
efficacy of different systems and control lipid digestion under conditions that simulate
the human gastrointestinal tract. The pH stat method used in this study is particularly
useful for the rapid screening of food emulsions and emulsion-based delivery systems
with different compositions and structures. The candidates successfully tested from
this digestion model can then be tested with more rigorous in vitro digestion models,
or using animal or human feeding studies(McClements and Li 2010).
The objective of this study is to compare the bioaccessibility differences between
crystalized nobiletin and solubilized nobiletin and between coarse nobiletin emulsion
and well-homogenized emulsion.
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4.2 Materials and Methods
Standard nobiletin was bought from Quality Phytochemicals, LLC (New Jersey,
USA).
4.2.1 Preparation of Nobiletin Enriched Emulsion and Corn Oil Emulsion
Bioactive Compounds Enriched Nanoemulsion Preparation: An oil phase was
prepared by dispersing 0.08% (w/w) nobiletin crystal into corn oil. An aqueous phase
was formed by mixing 0.5% (w/w) Tween 20 with aqueous buffer solution (10.0 mM
phosphate buffer saline, pH 7.0). Coarse emulsion was formed by mixing oil phase (4%
w/w) with aqueous phase (96% w/w) in a container, then use a high-speed blender
(Tissue-Tearor, Biospec Products, Bartlesville, OK) blending for 2 minutes at ambient
temperature. To make the well-homogenized nanoemulsion, the coarse emulsion was
then passed through a high-pressure microfluidizer (Model 101, Microfluidics,
Newton, MA) three times at 9,000psi.
Corn Oil emulsion Preparation: Oil-in-water nanoemulsions were prepared by
homogenizing 4%(w/w) corn oil with 96%(w/w) aqueous phase that was mixed by
dispersing 0.5% (w/w) Tween 20 with aqueous buffer solution (10.0 mM phosphate
buffer saline, pH 7.0). The following steps are as same as making nobiletin enriched
coarse emulsion and nobiletin enriched nanoemulsion.
4.2.2 Particle Characterization
The mean particle diameters (d43) and particle size distribution (PSD) of the
nanoemulsions were measured after mouth, stomach and small intestine digestion
using a static light scattering instrument (Mastersizer 2000 Malvern Instruments). The
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sizes of the particles in the unfiltered and filtered micelle phase were measured using
dynamic light scattering (ZetaSizer Nano, Malvern Instruments).
The electrical charge (z-potential) of the emulsion and the digesta of each step were
measured using a micro-electrophoresis instrument (Nano-ZS, Malvern Instruments,
Worcestershire, UK).
4.2.3 In vitro Digestion
Five comparative groups were prepared, which were nobiletin-enriched
nanoemulsion; nobiletin-enriched coarse emulsion; nobiletin crystals in corn oil
nanoemulsion and nobiletin crystals in coarse emulsion; nobiletin crystals in
phosphate buffer saline (PBS). The concentrations of nobiletin in the three groups
were the same. The methods of making the coarse and nanoemulsion were the same as
described in chapter two. Each sample was passed through a three-step simulated
gastrointestinal (GI) model that consisted of a mouth, gastric, and small intestine
phase. This model was established and described previously (Mun and McClements
2006).
Mouth phase: Simulated saliva fluid (SSF), containing 3% mucin and various salts,
was prepared as described in previous studies(Sarkar, Goh et al. 2009, Mao and
McClements 2012). Ten ml of sample was placed in a beaker and mixed with 10 ml of
SSF to make the oil concentration to be 2%. The mixture was then adjusted to pH 6.8
and placed in a shaker at 100 rpm and 37 ºC for 10 min to mimic oral conditions
(Innova Incubator Shaker, 132 Model 4080, New Brunswick Scientific, New Jersey,
USA).
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Gastric phase: Simulated gastric fluid (SGF) was prepared according to a
protocol described before (Sarkar, Goh et al. 2009). The “bolus” sample from the
mouth phase was mixed with SGF at a 1:1 mass ratio to make the final oil
concentration to be 1%. The mixture was then adjusted to pH 2.5 and placed in a
shaker at 100 rpm and 37 ºC for 10 min to mimic gastric conditions.
Small Intestine phase: Gastric digesta (30 ml) was incubated in a water bath (37 ºC)
for 10 min and then used NaOH solution to adjust the pH to 7.0. The 1.0 ml of CaCl2
solution, containing 110 mg of CaCl2 (pH 7.0, PBS) was added. Then 4 ml bile extract,
containing 187.5 mg bile extract (pH 7.0, PBS), was first added into the 30 ml digesta
with stirring and the resulting system was adjusted to pH 7.0. Finally, 2.5 ml of
pancreatic suspension, containing 60 mg of lipase (pH 7.0, PBS) was added to the
solution. At this point, titration was started automatically. The pH-stat (Metrohm,
USA Inc.) was used to monitor and control the pH (at pH 7.0) of the digestion solution.
As the triacylglycerol of fat was digested into free fatty acids by lipolysis, the NaOH
solution (0.25 M) was added in to neutralize the pH (7.0). With the volume of NaOH,
the amount of free fatty acids released in the system can be calculated. The whole
digestion lasted for 2 hours. The calculation of free fatty acids released was described
in the previous study (Li and McClements 2010).
4.2.4 Bioaccessibility Determination
After in vitro digestion, digesta of each sample group was collected and centrifuged
(14000 rpm, Thermo Scientific, CL10 centrifuge) at 25 ºC for 40 min. Centrifuged
samples separated into three phases: sediment phase at the bottom, a relatively clear
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water phase contained micelles in the middle, and sometimes an undigested oil phase
at top. The mixed micelles in the water phase were considered that entrapped the
bioactive components. The β-carotene was extracted using organic solvent
isopropanol-isooctane solution (1:1 volume ratio). Micelle phase or total digesta (0.2
ml) from the small intestine was added into 4.8 ml isopropanol-isooctane solution and
centrifuged at 4000 rpm at 25ºC for 10 min. Then the middle micelle phase was
passed through a syringe filter with the pore size of 0.45 um. Both the filtered and
unfiltered β-carotene concentration was analyzed using a UV-visible
spectrophotometer (Ultrospec 3000 pro, GE Health Sciences, USA) at the spectrum of
450 nm. The concentration of β-carotene was converted from the absorbance by the
standard curve. The bioaccessibility was calculated using the following equation:

⎛ C
⎞
Bioaccessibility = 100 × ⎜ Micelle ⎟
⎜ C
⎟
⎝ Digesta ⎠
In this equation, CMicelle and CDigesta are the concentrations of β-carotene in the
filtered and unfiltered micelle fraction and in the overall sample (total digesta) after
the pH-stat experiment, respectively.
4.2.5 Statistical analysis
All measurements were performed at least twice on freshly prepared samples and
were reported as calculated means and standard deviations.
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4.3 Results and Discussion
4.3.1 Nanoemulsion stability in digestion model

Mean Particle Diameter (um)

nobiletin emulsion
crystal in emulsion

nobiletin coarse emulsion
crystal in coarse emulsion
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1

0.1
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SI
Figure 14a. Influence of nobiletin on mean particle size. Influence of physical state
of nobiletin and size of emulsion and in vitro digestion on the mean diameter of the
particles in oil-in-water nanoemulsions subjected to a simulated gastrointestinal
model.

Both the initial particle size of the nanoemulsion groups, no matter with
soulubilized nobiletin or crystalized nobiletin, are comparatively small (d43=0.32 µm).
The initial particle sizes of the coarse emulsion groups are large (d43>16). After mouth
and stomach digestion, the sizes of nanoemulsion groups increased relatively
(d43>2.0). Meanwhile, after mouth and stomach digestion, the sizes of the coarse
emulsion groups didn’t increase a lot (d43>16). After small intestine digestion, sizes in
nanoemulsion groups increased dramatically (d43>8.0). There was also an obvious
increase of size in coarse emulsion groups (d43>22) (Figure 14a). The size
distributions of the nanoemulsion groups are monomodal. The size distributions after
mouth, stomach and small intestine are bimodal. The size distributions of all the
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digestion stages of coarse emulsion are monomodal. Particles all distributed at large
sizes (Figure 14b, 14c, 14d, 14e).
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Figure 14b. Particle size distribution of nobiletin nanoemulsion group. Influence
of in vitro digestion on the particle size distribution of oil-in-water emulsions
subjected to a simulated gastrointestinal model. Solubilized nobiletin nanoemulsion.	
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Figure 14c. Particle size distribution of nobiletin coarse emulsion group. Influence
of in vitro digestion on the particle size distribution of oil-in-water emulsions
subjected to a simulated gastrointestinal model. Solubilized nobiletin coarse emulsion.
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Figure 14d. Particle size distribution of nobiletin crystal nanoemulsion group.
Influence of in vitro digestion on the particle size distribution of oil-in-water
emulsions subjected to a simulated gastrointestinal model. Crystalized nobiletin in
nanoemulsion.
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Figure 14e. Particle size distribution of nobiletin cryastal coarse emulsion group.
Influence of in vitro digestion on the particle size distribution of oil-in-water
emulsions subjected to a simulated gastrointestinal model. Crystalized nobiletin in
coarse emulsion.
	
  

	
  

42	
  

The initial nanoemulsions of all the groups are negatively charged, but the magnitude
is small. Although Tween20 is a non-ionic surfactant, however, there may be anionic
impurities (e.g. free fatty acids and phospholipids) presenting within the surfactant or
lipid phase that could adsorb to the oil-water interface and gave a negative charge on the
droplets. After the small intestinal stage, the particles charges appeared to be the most
negative, which is due to adsorption of anionic species (e.g., bile salts, phospholipids,
lipases) to the droplets surfaces (Figure 15).
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Figure 15. Influence of nobiletin on particle charge. Influence of physical state of
nobiletin and size of emulsion and in vitro digestion on the charge (ζ-potential) of the
particles in oil-in-water emulsions subjected to a simulated gastrointestinal model.
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Figure 16. Influence of nobiletin on micelles size. Influence of physical states of
nobiletin on the micelle phase sizes (represent by Z-average) collected after digestion and
centrifugation. Measurements were made before and after filtration.
After simulated small intestine digestion, the digesta were collected and centrifuged.
Three layers formed: the bottom sediment phase, the middle micelle phase and the top
undigested oil phase. The “micelle” phase was collected and filtered through 0.45 pre size
filters. The particle size and electrical charges of both the filtered and unfiltered micelles
were measured (Figure 15,16). The sizes in the unfiltered groups are larger indicated that
the middle phase are mainly mixed micelles and thin-walled vesicles. After filtration the
size decreased as expected, suggesting that some large vesicles were filtered out. The
sizes of the crystalized groups are larger than the solubilized groups. The sizes of the
solubilized nobiletin groups are smaller, regardless of the original sizes of emulsion. The
electrical charges of the unfiltered and filtered micelles are also negative (Figure 15)
because of the anionic species, such as bile salts, phospholipids and free fatty acids.
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4.3.2 Lipid Digestion via In Vitro Digestion
In this section, we monitored the rate and extent of lipid digestion in the small
intestinal digestion via pH-stat. This method measured the amount of free fatty acids
(FFAs) released from triglycerides under the digestion of lipase(McClements and Li
2010). As expected, there was little change in the pH of the sample only contained
nobiletin crystals and PBS, because there is no fat in the system and no FFAs released
during digestion (Figure 17). In this sample, the slightly increase in the amount of NaOH
due to the digestion of Tween 20. In the nanoemulsion systems, there was a dramatic
increase in the first 20 minutes of digestion and then it gradually reached a plateau; the
increases in the coarse groups were relatively slow (Figure 17). The FFAs release
profiles followed a similar trend as the NaOH consumption (Figure 18). The trend
suggested that lipase attached to the surface of the lipid droplets rapidly and promoted
triglycerol digestion.
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Figure 17. Volume of NaOH. Influence of physical state of nobiletin and emulsion size
on the pH-stat titration curves of oil-in-water nanoemulsions. The curves show the
volume of 0.25 M NaOH solution that had to be added to the samples to maintain the pH
at a constant value of 7.
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Figure 18. Free fatty acids released percentage. Influence of physical state of nobiletin
and emulsion size on the pH-stat titration curves of oil-in-water nanoemulsions. The
curves show the calculated percentage of free fatty acids (FFA) released from the
nanoemulsions after digestion of the triacylglycerol phase by lipase.	
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4.3.3 In Vitro Digestion Bioaccessibility
In this section, we examined the nobiletin bioaccessibility under solubilized state and
crystalized state and with nanoemulsion and conventional emulsion after it passed
through the simulated gastrointestinal tract model. Theoretical, the portion of nobiletin in
“micelle” phase over the portion of original nobiletin can represent the nobiletin
bioaccessibility. The bioaccessibilty was measured before and after filtration. It was
assumed that the filtered sample could be more practically represent the actual
bioaccessibility of nobiletin because it could remove any particles larger than 450nm that
could not be absorbed by small intestine epithelium cells. The filter mimicked the
function of the mucus layer above the small intestine.
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Figure 19. Nobiletin bioaccessibility. Effect of physical states of nobiletin and emulsion
size on bioaccessibility of nobiletin measured after centrifugation of emulsions passed
through an in vitro digestion model.
	
  

47	
  

The lowest bioaccessibility (22.0%) was measured in filtered nobiletin crystals with
PBS (Figure 19). The bioaccessiblity of solubilized nobiletin in nanoemulsion is higher
than coarse emulsion. The bioaccessibility of nobiletin crystals in coarse emulsion is
lower than nanoemulsion. Comparing the solublized ones with the crystalized ones, the
bioaccessibilies of the solubilized groups are larger than the crystalized groups. The
solubilized nobiletin nanoemulsion enjoyed the highest bioaccessibility. This is because
when added nobiletin crystals in either corn oil emulsion or PBS, most of the nobiletin
still stayed unsolubilized. Although nobiletin better in corn oil emulsion than only in PBS,
however compared with the solubilized nobiletin emulsion, the solubilized part was still
too few to have a high bioaccessibilty. These results suggested people to take solubilized
nobiletin supplements to get the best absorption in gastrointestinal tract.
4.4 Conclusions
This study showed the bioaccessibility of different physical states of nobiletin and
with different delivery systems is different. In the five compare groups: (1) solubilized
nobiletin nanoemulsion, (2) solubilized nobiletin conventional emulsion, (3) nobiletin
crystals in nanoemulsion, (4) nobiletin crystals in conventional emulsion, (5) nobiletin
crystals in PBS, the rate and extent of free fatty acid production in the small intestine
decreased in the order (3)>(1)>(4)>(2)>(5); whereas the nobiletin bioaccessibility
decreased in the order (1)>>(2)>(3)>(4)>(5). In system (5), even without any fat, there
was still noticeable consumption of NaOH, which was attributed to hydrolysis of the ester
bonds in the non-ionic surfactant (Tween 20). The low bioaccessibility (22%) of system
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(5) was attributed to the fact that there were few free fatty acids produced to form mixed
micelles to solubilize β-carotene. The bioaccessibility of nobiletin crystals groups are
generally lower than soulubilized groups, which suggests that crystalline nobiletin is less
bioaccessible than soluble nobiletin.
The bioaccessibility of solubilized nobiletin entrapped in nanoemulsions was the
highest is because the free fatty acids produced through small intestine digestion formed
mixed micelles capable of solubilizing and transporting lipophilic compounds. Crystalline
nobiletin was not incorporated into mixed micelles easily, leading to a reduced
bioaccessibility. In the system with crystals in water, there was no free fatty acid
produced, so the bioaccessibility of nobiletin was low.
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